Healthcare Market Research Reports

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 07 Nov 2017  |  North America  |  Market Research

    Growth Insights on the US Therapeutic Apheresis Market, Forecast to 2021

    Product Diversification, Focus on Therapeutic Plasmapheresis and Pathogen-Reduced Platelets Will Be Key to Success

    The study covers current and future market trends, drivers, challenges, and opportunities in US therapeutic apheresis market. It breaks down the market into hematology and oncology, neurology, rheumatology, and other therapeutic areas. Therapeutic apheresis has become an essential element of the blood and blood components industry value chain. Hosp...

    $1,500.00
  2. 06 Nov 2017  |  North America  |  Market Research

    Global Computed Tomography Market, Forecast to 2021

    With Minimal Technological Differentiation, Stake Holders Focus on Value Based Products and Operational Expenditure Models

    The study aims to analyze and forecast the Computed Tomography market in North America (the United States and Canada), Europe and Asia-Pacific countries for 2016. Research Scope: Market trends (Utilization of conventional and emerging clinical applications, growth indicators, factors influencing ROI, critical unmet needs and potential game changi...

    $4,950.00
  3. 31 Oct 2017  |  North America  |  Market Research

    Growth Insights on the Global CRISPR/Cas9 Tools Market, 2017

    A Disruptive Technology—Gene-editing Tools for Multiple Applied Industries

    Since its inception, CRISPR has gained strong traction from the global research community because of its huge potential in diverse applications. Considering CRISPR’s disruptive and game-changing applications, a number of large and small participants have invested in this domain. Along the same line, CRISPR has witnessed a multi-fold uptake in fun...

    $3,000.00
  4. 31 Oct 2017  |  North America  |  Market Research

    Assessment of the US Revenue Cycle Management Market, Forecast to 2022

    How Value-Based Care is Transforming the Ecosystem

    Revenue cycle management (RCM) refers to myriad administrative and clinical functions around the capture, management, and collection of patient service revenue. The RCM process starts with admission (patient access) and continues through to accounts receivable (payment and collections). A variety of RCM solutions (e.g., IT applications and services...

    $4,950.00
  5. 30 Oct 2017  |  North America  |  Market Research

    Transformation of the United States Medical Imaging Industry, 2017

    Consolidations, Process Automation, and Emphasis on Interoperability Drive Greater Standardization and Integration of Imaging in Clinical Care Pathways

    The US medical imaging industry is undergoing a transformation with stakeholders across the ecosystem emphasizing collaborative population health-based approaches over conventional episode-based models of care delivery. Current reimbursement and regulatory factors are pushing the imaging industry away from a “get bigger” approach that emphasize...

    $4,950.00
  6. 25 Oct 2017  |  North America  |  Market Research

    Digital Health Market Profile—Fitbit

    Fitbit is Losing Steps as the Wearable Market Matures

    Digital health brings a diverse range of growth opportunities for vendors across the value chain. As the space has evolved, it has experienced a multitude of small successes and stellar failures, yet funding continues to flood in. Major entries into the industry continue from the broader vendor environment, underlining the importance of health in e...

    $1,500.00
  7. 26 Sep 2017  |  North America  |  Market Research

    US Telemental Health Market, Forecast to 2021

    Opportunities to Offer a Variety of Telebehavioral Health Services Will Drive New Growth in Digital Health

    The latest report in the Frost & Sullivan's telehealth series finds that telemental health services and communications enablers are poised to increase in utilization because they offer a therapeutic environment similar to traditional in-person methods, minus the time and costs associated with traveling to a treatment site—assuming one is even ava...

    $4,950.00
  8. 25 Sep 2017  |  North America  |  Technology Research

    Technology Innovations for Patient Engagement

    Digital Technologies Transforming Patient Engagement Industry

    Patient engagement is crucial to better clinical outcomes and a high-performing health system. Patient engagement improves communication between the patients and their care providers, resulting in timely access to healthcare, reduces hospital re-admissions, and enables efficient management of illness. This research service showcases the different t...

    $4,950.00
  9. 25 Sep 2017  |  North America  |  Market Research

    2017 Customer Attitudes and Adoption Plans of Digital Pathology Technologies

    A Voice of Customer Study to Compare Trends Between Current and Potential Adopters of Digital Pathology Platforms

    A digital pathology end-user research was conducted to identify trends and developments in the field of digital pathology. The survey sought to collect the key information on usage and adoption and compare the perceptions of current and potential adopters of this technology. For the survey, lab managers and pathologists of pathology facilities we...

    $4,950.00
  10. 19 Sep 2017  |  North America  |  Market Research

    Global Healthcare Service as Product Solutions, 2016

    Medical Device OEMs are Starting to Share the Responsibilities of Patient Outcomes and Profit Margins with Providers

    Servicization of healthcare with innovative Platform-as-a-Service (PaaS) and Data-as-a-Service (DaaS) models are opening new revenue streams for medical device OEMs and are driving the future sustainability. Focus on Healthcare: As the focus of providers shift from treatment to diagnosis, prevention, and monitoring, PaaS and DaaS are expected to ...

    $1,500.00